Population pharmacokinetics of meropenem
... in patients undergoing automated peritoneal dialysis
Recent publication
Investigation of the drug Meropenem for the treatment of peritonitis in peritoneal dialysis with Professor Dr Martin Wiesholzer, Head of the Clinical Department of Internal Medicine 1 at University Hospital St. Pölten. The effect and the administered amount of the intravenously or intraperitoneally administered drug were statistically evaluated and assessed.
The study was published in the journal „Peritoneal Dialysis International“.
Ullah S, Ursli M, Fuhr U, Wiesholzer M, Kussmann M, Poeppl W et al. Population pharmacokinetics of meropenem in patients undergoing automated peritoneal dialysis. Peritoneal Dialysis International. 2023 May 2;8968608231167237. Epub 2023 May 2. doi: 10.1177/08968608231167237
Prim. Clin. Ass. Prof. Dr. Martin Friedrich Wiesholzer
Division of Internal Medicine 1 (University Hospital St. Pölten)
